Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bigmar, Inc. (OTC BB:BGMR.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Location
9711 Sportsman Club Road
Johnstown, OH 43031
Phone: (740) 966-5800
Fax: (740) 966-5801
Email: info@bgmr.com
Employees (last reported count): 82
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 67%
·Institutional: 2% (5% of float)
(one institution)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bigmar, Inc. manufactures generic oncology pharmaceuticals and related products (Oncology Products) and intravenous infusion solutions through its subsidiaries, and markets these products in Europe, the United States and other countries primarily through pharmaceutical distributors. The Company has three wholly owned subsidiaries. Bioren SA is engaged in manufacturing and marketing various pharmaceutical products in Switzerland. Products include 22 types of intravenous infusion solutions and other related products. Bigmar Pharmaceuticals SA manufactures and markets Oncology Products such as Calcium Leucovorin, Sodium Folinate, Dacarbazine, Doxorubicin, Etoposide, Fluorouracil, Daunorubicin, Methotrexate and Cisplatin. The Oncology Products are marketed in the United States, Italy, Germany, Switzerland, Brazil, Greece and Spain. Bigmar Therapeutics is essentially a shell company and had no significant business operations, as of December 31, 2000.
More from Market Guide: Expanded Business Description

Financial Summary
BGMR is engaged in the manufacturing and marketing of pharmcueticals products in Switzerland. Current products include 22 types of intravenous infusion solutions and other related products. For the three months ended 3/31/01, revenues rose 29% to $2.3 million. Net loss before extraordinary item remained flat at $1.3 million. Revenues reflect increased sales volumes in European markets. Net loss was partially offset by decreased R&D expenses.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 2,200; after tax earnings were -1,497. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

John Tramontana, 54
Chairman, CEO
$207K
Cynthia May, 48
Pres, Director
--  
Bernard Kramer, 46
COO, VP, Director
--  
Massimo Pedrani, 45
Exec. VP of R&D
--  
Declan Service, 40
VP-Bus. Devel., Director
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:BGMR.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 8-Jan-2001
$1.00 
Recent Price$1.299
52-Week High
on 6-Oct-2000
$3.00 
Beta-0.58 
Daily Volume (3-month avg)3,773 
Daily Volume (10-day avg)4,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-38.9%
52-Week Change
relative to S&P500
-18.0%
Share-Related Items
Market Capitalization$13.2M
Shares Outstanding10.2M
Float3.40M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$0.42 
Earnings (ttm)-$0.55 
Earnings (mrq)-$0.16 
Sales (ttm)$0.83 
Cash (mrq*)$0.03 
Valuation Ratios
Price/Book (mrq*)3.08 
Price/EarningsN/A 
Price/Sales (ttm)1.56 
Income Statements
Sales (ttm)$8.25M
EBITDA (ttm*)-$2.95M
Income available to common (ttm)-$5.46M
Profitability
Profit Margin (ttm)-66.2%
Operating Margin (ttm)-54.9%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-30.11%
Return on Equity (ttm)-352.97%
Financial Strength
Current Ratio (mrq*)0.65 
Debt/Equity (mrq*)2.25 
Total Cash (mrq)$0 
Short Interest
As of 9-Oct-2000
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume22.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.